U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3330133301Can We Improve the Quality of Care at the End of Life in Israel?Not yet recruitingNo Results AvailableEnd of Life ProcessBehavioral: Simulation traininghttps://ClinicalTrials.gov/show/NCT02129283
3330233302Hematoma Block for Reduction of Distal Radius FracturesNot yet recruitingNo Results AvailableFractures of the Distal RadiusDrug: Lidocaine HCl 2% .|Drug: Lidocaine HCl 1%https://ClinicalTrials.gov/show/NCT02129270
3330333303Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal CancerRecruitingNo Results AvailableMetastatic Colorectal CancerDrug: AFLIBERCEPT|Drug: Irinotecan|Drug: 5-Fluorouracil|Drug: Folinic Acidhttps://ClinicalTrials.gov/show/NCT02129257
3330433304A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection OutcomesRecruitingNo Results AvailableMDR-TB|HIVOther: NCM-Plushttps://ClinicalTrials.gov/show/NCT02129244
3330533305Statins for Oxidative Stress and Mitochondrial Function in Diabetic PolyneuropathyCompletedNo Results AvailableOxidative Stress|Diabetic PolyneuropathyDrug: calcined magnesia|Drug: Ezetimibe/simvastatin|Drug: Rosuvastatinhttps://ClinicalTrials.gov/show/NCT02129231
3330633306Low Glycemic Load Diet in Patients With Stage I-III Colon CancerRecruitingNo Results AvailableStage I-III Colon CancerOther: questionnaire administration|Other: laboratory biomarker analysis|Behavioral: Standard Dietary Intervention|Behavioral: Intensified Dietary Intervention|Behavioral: Low glycemic load|Behavioral: Medium Glycemic Loadhttps://ClinicalTrials.gov/show/NCT02129218
3330733307A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid TumorsRecruitingNo Results AvailableNeoplasms|Breast CancerDrug: PF-06650808|Drug: PF-06650808https://ClinicalTrials.gov/show/NCT02129205
3330833308Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant UseCompletedNo Results AvailableHealthyDrug: Amlodipine 5mg capsule|Drug: T80/H12.5 mg FDC tablet|Drug: T80/A5/H12.5 mg FDC tablethttps://ClinicalTrials.gov/show/NCT02129192
3330933309The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart FailureNot yet recruitingNo Results AvailableHeart FailureDrug: Glucagon-Like Peptide 1https://ClinicalTrials.gov/show/NCT02129179
3331033310Explore the Synergy of Combination TKI TherapyWithdrawnNo Results AvailableHealthy VolunteersDrug: Dasatinib|Drug: Dasatinib+Imatinibhttps://ClinicalTrials.gov/show/NCT02129166
3331133311Linking Families Together Study- A Randomized Trial to Raise Parental MonitoringEnrolling by invitationNo Results AvailableAdolescent Behaviors|Substance AbuseBehavioral: LIFT (Parent Information)https://ClinicalTrials.gov/show/NCT02129153
3331233312Observational Study to Evaluate Ventral Incisional Hernia Repair Using a Biologic Mesh (Cook Biodesign)RecruitingNo Results AvailableVentral Incisional HerniaDevice: Hernia graft/meshhttps://ClinicalTrials.gov/show/NCT02129140
3331333313Drug-Coated Chocolate PTA Balloon in Patients With Peripheral Arterial Disease - The ENDURE TrialRecruitingNo Results AvailablePeripheral Vascular DiseaseDevice: Paclitaxel Coated Chocolate Balloon Angioplastyhttps://ClinicalTrials.gov/show/NCT02129127
3331433314Study to Evaluate the Safety and Efficacy of Dural Repair Patch in Neurosurgical RepairsRecruitingNo Results AvailableNeurosurgical RepairsDevice: ReDura Onlay|Device: DuraGenhttps://ClinicalTrials.gov/show/NCT02129114
3331533315Azacitidine and Erismodegib in Treating Patients With Myeloid MalignanciesRecruitingNo Results AvailableAdult Acute Megakaryoblastic Leukemia|Adult Acute Monoblastic Leukemia|Adult Acute Monocytic Leukemia|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With Maturation|Adult Acute Myeloid Leukemia With Minimal DiDrug: Azacitidine|Drug: Erismodegib|Other: Quality-of-Life Assessment|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT02129101
3331633316A Pharmacokinetic, Safety and Tolerability Study of Esketamine in Healthy Elderly and Adult ParticipantsCompletedNo Results AvailableHealthyDrug: Esketamine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02129088
3331733317CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301in Treating Patients With Stage IIB-IV MelanomaRecruitingNo Results AvailableCarcinoma of Unknown Primary Origin|Iris Melanoma|Medium/Large Size Posterior Uveal Melanoma|Mucosal Melanoma|Ocular Melanoma With Extraocular Extension|Small Size Posterior Uveal Melanoma|Stage IIB Skin Melanoma|Stage IIB Uveal Melanoma|Stage IIC Skin MeBiological: DEC-205/NY-ESO-1 Fusion Protein CDX-1401|Other: Laboratory Biomarker Analysis|Biological: Neoantigen-based Melanoma-Poly-ICLC Vaccine|Other: Pharmacological Study|Biological: Recombinant Flt3 Ligandhttps://ClinicalTrials.gov/show/NCT02129075
3331833318Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic LeukemiaRecruitingNo Results AvailableAdult B Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1|Recurrent Adult Acute Lymphoblastic LeukemiaDrug: Ibrutinib|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT02129062
3331933319Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their ChildrenActive, not recruitingNo Results AvailableBreast Cancer|Cervical Cancer|Colon Cancer|Leukemia|Lymphoma|Malignant Neoplasm|Melanoma|Rectal CancerOther: educational intervention|Behavioral: telephone-based intervention|Other: questionnaire administrationhttps://ClinicalTrials.gov/show/NCT02129049
3332033320Ovarian Clear Cell Adenocarcinoma ReviewCompletedNo Results Available[M]Ovarian Cystadenoma or Carcinomahttps://ClinicalTrials.gov/show/NCT02129036
3332133321The Impact of Exergame on User HealthActive, not recruitingNo Results AvailableImpact of Exergame Use on User HealthDevice: Xbox 360https://ClinicalTrials.gov/show/NCT02129023
3332233322The Pathogenesis of Terson Syndrome and the Role of CSF Tau / Amyloid-ß 40 and 42 in Patients With Aneurysmatic Subarachnoid HemorrhageActive, not recruitingNo Results AvailableSubarachnoid Hemorrhage|Terson Syndrome|CSF-proteineshttps://ClinicalTrials.gov/show/NCT02129010
3332333323PROphylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese PopulationRecruitingNo Results AvailableTo Assess is There a Method to Decrease Wound Complication Rates Among Obese Patients After Cesarean SectionDevice: Closed incision wound vacuum (Prevena)https://ClinicalTrials.gov/show/NCT02128997
3332433324Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished ChildrenCompletedNo Results AvailableCystic Fibrosis|Failure to Thrive|MalnutritionDietary Supplement: Symbiotic Formula with DHA and antioxidants|Dietary Supplement: Standard Formulahttps://ClinicalTrials.gov/show/NCT02128984
3332533325A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and PlaceboRecruitingNo Results AvailableAnemiaDietary Supplement: Ferrochel® 90 mg|Dietary Supplement: Sumalate® 90 mg|Dietary Supplement: Ferrous fumarate 90 mg|Dietary Supplement: Ferrous Sulfate 90 mg|Dietary Supplement: Ferric Glycinate 90 mg|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT02128971
3332633326Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)RecruitingNo Results AvailableHepatocellular CarcinomaDrug: CF102|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02128958
3332733327Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid MalignanciesRecruitingNo Results AvailableUntreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma PatientsOther: [18F] - Fludarabine PET/CThttps://ClinicalTrials.gov/show/NCT02128945
3332833328Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: semaglutide|Drug: semaglutide|Drug: insulin glarginehttps://ClinicalTrials.gov/show/NCT02128932
3332933329Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in SchizophrenicRecruitingNo Results AvailableSchizophrenia|Cognition|Cigarette SmokingDevice: tDCShttps://ClinicalTrials.gov/show/NCT02128919
3333033330Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction DesignRecruitingNo Results AvailableSquamous Cell Carcinoma of the Oropharynx, Larynx, or HypopharynxDrug: Cisplatin|Radiation: IMRT|Drug: Docetaxel|Drug: Cetuximabhttps://ClinicalTrials.gov/show/NCT02128906

* Görseller ve İçerik tekif hakkına sahip olabilir